Biotech 2050 Podcast
71. Leadership in immuno-oncology, Jeffrey Goldberg, President and CEO, Immunitas Therapeutics
over 3 years ago
70. Modern treatments for psoriasis and atopic dermatitis, Todd Zavodnick, CEO, Dermavant Sciences
over 3 years ago
69. Antibodies in immuno-oncology, Alison O'Neill, Chief Medical Officer, Surface Oncology
over 3 years ago
68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals
over 3 years ago
67. ML protein therapy, Mike Nally, CEO, and Geoff von Maltzahn, Co-Founder, Generate Biomedicines
over 3 years ago
66. I’ll take “Wild Rides” for 500, Alex: Biotech Entrepreneur’s Story, Ron Cohen, CEO, Acorda
over 3 years ago
65. Patient focused precision oncology, Avanish Vellanki, Cofounder and CEO, Rain Therapeutics
over 3 years ago
64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark
over 3 years ago